Transmission of resistant HIV type 1 variants and epidemiological chains in Italian newly diagnosed individuals.

Transmission of HIV-1 and drug resistance continue to occur at a considerable level in Italy, influenced mainly by changes in modality of infection. However, the long period of infectivity makes difficult the interpretation of epidemiological networks, based on epidemiological data only. We studied 510 naive HIV-1-infected individuals, of whom 400 (78.4%) were newly diagnosed patients with an unknown duration of infection (NDs), with the aim of identifying sexual epidemiological networks and transmitted drug resistance (TDR) over a 7-year period. Clusters were identified by Bayesian methods for 412 patients with B subtype; 145 individuals (35.2%) clustered in 34 distinct clades. Within epidemiological networks males were 93.1% (n=135); the same proportion of patients has been infected by the sexual route; 62.1% (n=90) were men having sex with men (MSM) of whom 67.8% (n=61) were NDs. Among heterosexuals (n=44), males were predominant (79.5%, n=35) and 77.3% (n=34) were NDs. TDR in clusters was 11.7 % (n=17), of whom 76.5% (n=13) was found in MSM. TDR was predominantly associated with NRTI resistance in individuals with chronic infection (n=11). A high prevalence of epidemiological networks has been found in the metropolitan area of Milan, indicating a high frequency of transmission events. The cluster analysis of networks suggested that the source of new infections was mainly represented by males and MSM who have long lasting HIV-1 infection. Notably, the prevalence of resistance-conferring mutations was higher in chronically infected patients, carrying mainly resistance to thymidine analogs, the backbone of first antiretroviral (ARV) generation. Intervention strategies of public health are needed to limit HIV-1 transmission and the associated TDR.

[1]  M. Salemi,et al.  Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[2]  M. Zazzi,et al.  Changing patterns in HIV‐1 non‐B clade prevalence and diversity in Italy over three decades * , 2010, HIV Medicine.

[3]  Matthias Cavassini,et al.  Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. , 2010, The Journal of infectious diseases.

[4]  M. Ciccozzi,et al.  Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy. , 2010, AIDS research and human retroviruses.

[5]  R. Maserati,et al.  Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors. , 2009, The Journal of antimicrobial chemotherapy.

[6]  Bernard Hirschel,et al.  The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection , 2009, AIDS.

[7]  O. Pybus,et al.  Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach , 2009, Retrovirology.

[8]  Spread programme,et al.  Transmission of drug-resistant HIV-1 in Europe remains limited to single classes , 2008, AIDS.

[9]  A. Rambaut,et al.  Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics , 2008, PLoS medicine.

[10]  A. Rambaut,et al.  BEAST: Bayesian evolutionary analysis by sampling trees , 2007, BMC Evolutionary Biology.

[11]  G. Fadda,et al.  Declining Prevalence of HIV-1 Drug Resistance in Treatment-Failing Patients: A Clinical Cohort Study , 2007, Antiviral therapy.

[12]  Jörg Schüpbach,et al.  Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey , 2007, AIDS.

[13]  John P. Walsh,et al.  Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom , 2007, AIDS.

[14]  Michel Roger,et al.  High rates of forward transmission events after acute/early HIV-1 infection. , 2007, The Journal of infectious diseases.

[15]  Tony O’Hagan Bayes factors , 2006 .

[16]  D. Pillay,et al.  Prevalence of Transmitted HIV-1 Drug Resistance and the Role of Resistance Algorithms: Data From Seroconverters in the CASCADE Collaboration From 1987 to 2003 , 2005, Journal of acquired immune deficiency syndromes.

[17]  Andrew Rambaut,et al.  Comparative population dynamics of HIV-1 subtypes B and C: subtype-specific differences in patterns of epidemic growth. , 2005, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[18]  Stéphane Hué,et al.  Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Deenan Pillay,et al.  Current Patterns in the Epidemiology of Primary HIV Drug Resistance in North America and Europe , 2004, Antiviral therapy.

[20]  D. Pillay,et al.  Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000. , 2004, The Journal of antimicrobial chemotherapy.

[21]  Elizabeth Connick,et al.  Antiretroviral-drug resistance among patients recently infected with HIV. , 2002, The New England journal of medicine.

[22]  J. Kahn,et al.  Time trends in primary HIV-1 drug resistance among recently infected persons. , 2002, JAMA.

[23]  M. Moroni,et al.  Increasing Prevalence of Non‐Clade B HIV‐1 Strains in Heterosexual Men and Women, as Monitored by Analysis of Reverse Transcriptase and Protease Sequences , 2001, Journal of acquired immune deficiency syndromes.

[24]  John P. Huelsenbeck,et al.  MRBAYES: Bayesian inference of phylogenetic trees , 2001, Bioinform..

[25]  M. Suchard,et al.  Bayesian selection of continuous-time Markov chain evolutionary models. , 2001, Molecular biology and evolution.